Nonpharmacological dyspnoea-relief strategies in lung cancer: a systematic review and network meta-analysis
Clinical Snapshot
PICO Framework
| P — Population | Lung cancer patients experiencing dyspnoea |
| I — Intervention | Nonpharmacological dyspnoea-relief strategies (acupressure, fan therapy, multicomponent interventions, cognitive behavioural therapy, etc.) |
| C — Comparator | Control groups or other nonpharmacological interventions |
| O — Outcomes | Dyspnoea score post-intervention (primary outcome) |
Bottom Line
This comprehensive network meta-analysis of 46 RCTs involving 4138 lung cancer patients demonstrates that acupressure is the most effective nonpharmacological intervention for dyspnoea relief, with a large effect size (Hedges' g -1.96). Fan therapy and multicomponent interventions also showed significant benefits. For post-operative patients specifically, multicomponent interventions were most effective, while acupressure and fan therapy were optimal for patients with pre-existing dyspnoea. These findings provide evidence-based guidance for clinicians managing this distressing symptom in lung cancer care. The interventions are generally accessible and can be integrated into existing care pathways. However, the abstract lacks important methodological details regarding risk of bias assessment and heterogeneity evaluation, which limits full confidence in the findings.
Key Findings
P Value: Not reported in abstract
Effect Size: Acupressure: Hedges' g -1.96 (large effect); Fan therapy: Hedges' g -1.11 (large effect); Multicomponent: Hedges' g -1.01 (large effect)
Primary Outcome: Dyspnoea score post-intervention
Nnt Or Sensitivity: SUCRA rankings: Acupressure 98.7%, Fan therapy 83.7%, Multicomponent interventions 80.7%
Confidence Interval: Acupressure: 95% CI -2.92 to -0.99; Fan: 95% CI -1.72 to -0.50; Multicomponent: 95% CI -1.49 to -0.52
Clinical Application
Nonpharmacological interventions are generally accessible and can complement standard care without significant resource requirements Relevant to Australian oncology and palliative care settings; interventions align with Cancer Australia guidelines emphasising supportive care; applicable across public and private healthcare systems Lung cancer patients with dyspnoea, including post-operative patients and those with pre-existing breathlessness
Abstract
BACKGROUND: Dyspnoea is a common and distressing symptom in lung cancer patients. While various dyspnoea-relief strategies show promise, their comparative effectiveness remains unclear. METHODS: We conducted a systematic review and network meta-analysis of randomised controlled trials on nonpharmacological dyspnoea-relief strategies in lung cancer patients, using studies published until 12 June 2025 from the databases PubMed, Embase, Web of Science, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform. The primary outcome was dyspnoea score post-intervention. RESULTS: 4138 participants from 46 randomised controlled trials were included in the analysis. Among 10 nonpharmacological dyspnoea-relief strategies in lung cancer patients, acupressure (surface under the cumulative ranking curve (SUCRA) 98.7%, Hedges' g -1.96, 95% CI -2.92 to -0.99) demonstrated the highest efficacy, followed by fan (SUCRA 83.7%, Hedges' g -1.11, 95% CI -1.72 to -0.50), and multicomponent interventions (SUCRA 80.7%, Hedges' g -1.01, 95% CI -1.49 to -0.52). In post-operative lung cancer patients, multicomponent interventions (SUCRA 97.4%, Hedges' g -1.55, 95% CI -2.16 to -0.94) were the most effective, followed by cognitive behavioural therapy (SUCRA 74.8%, Hedges' g -0.90, 95% CI -1.75 to -0.05). For patients with pre-existing dyspnoea, acupressure (SUCRA 90.9%, Hedges' g -1.72, 95% CI -3.01 to -0.42) and fan therapy (SUCRA 77.3%, Hedges' g -1.18, 95% CI -2.10 to -0.27) were the top interventions. CONCLUSIONS: Acupressure is the primary strategy for alleviating dyspnoea in lung cancer patients, including those with pre-existing dyspnoea, followed by fan therapy, while multicomponent interventions are recommended for post-operative patients.
References
- 1.Hu, G., Koirala, B., Young, L., Liang, C., Zhou, W., & Zhang, Q. (2026). Nonpharmacological dyspnoea-relief strategies in lung cancer: a systematic review and network meta-analysis. European Respiratory Review. https://doi.org/10.1016/j.jpainsymman.2023.03.002
Related Research
Sleep medicine
Concordance of wearable device sleep metrics with patient-reported sleep quality: A systematic review
3 Aug 2026
Bioelectrochemistry (Amsterdam, Netherlands)
From data to diagnosis: A comprehensive review of machine learning-driven wearable sensors in healthcare.
2 Aug 2026
JMIR mHealth and uHealth
Wearable Devices for Monitoring and Management of Comorbid Obstructive Sleep Apnea and Hypertension: Scoping Review
1 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service